1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bella, R; Cantone, M; Ferri, R; Fisicaro, F; Lanza, G; Pennisi, G; Pennisi, M | 1 |
| Agrawal, A; Bhattacharya, A; Kamble, N; Mailankody, P; Pal, PK; Yadav, R | 1 |
2 other study(ies) available for 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Cognitive Decline
| Article | Year |
|---|---|
Sex differences in mild vascular cognitive impairment: A multimodal transcranial magnetic stimulation study.
Topics: Anthropometry; Cognitive Dysfunction; Female; Humans; Male; Sex Characteristics; Transcranial Magnetic Stimulation | 2023 |
Cortical excitability changes in patients of vascular parkinsonism with cognitive impairment.
Topics: Aged; Cognitive Dysfunction; Cortical Excitability; Evoked Potentials, Motor; Humans; Middle Aged; Neural Inhibition; Transcranial Magnetic Stimulation | 2023 |